Not only is MRI-guided intravenous thrombolysis cost-effective, but the approach offers long-term clinical benefits for stroke patients with no known time of onset.

A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

The U.S. Department of Veterans Affairs (VA) has launched the National Artificial Intelligence Institute (NAII) to develop AI research for improving the health and well-being of U.S. veterans. 

The relationship between CMS Administrator Seema Verma and HHS Secretary Alex Azar has become so fraught that both President Trump and Vice President Pence have stepped in to try to “salvage the situation,” which has threatened to undermine the administration’s healthcare agenda, Axios reported, citing three senior administration officials.

CT colonography’s uphill climb may only get steeper, as researchers have achieved 100% accuracy identifying cancers below the surface of colorectal tissue by combining optical coherence tomography with deep learning.

National healthcare expenditures rose 4.6% in 2018, according to new figures from the CMS Office of Actuary.

A performance-related financial incentive scheme for general practitioners in the U.K. led to a nearly five-fold increase in the number of heart patients doctors said had been “cured” of atrial fibrillation, according to a recent analysis.

AI models can be trained to evaluate chest x-rays as well as radiologists, according to a new study published by Radiology. Specialist-approved reference standards played a crucial role in the team’s research.

With the agreement, Inspira Health plans to standardize diagnostic technology across its dozen-plus facilities, including three hospitals. 

European researchers have trained and validated a deep-learning algorithm for quantifying prostate measurements on PET/CT scans. They also showed that the measurements can serve as biomarkers useful in formulating clinical prognoses for prostate cancer patients.